CliffordMitsuoTakemotoMD

PubMed

• Utility of Caregiver Signaling Questions to Detect Neurocognitive Impairment in Children with Sickle Cell Disease.
  Christina M Dandar, Lakia Kearson, Jennifer N Longoria, Brian Potter, Allison A King
  Blood Advances. 2024-11-13
• A Novel One-Sample Mendelian Randomization Approach for Count-Type Outcomes That Is Robust to Correlated and Uncorrelated Pleiotropic Effects.
  Janaka S S Liyanage, Jane S Hankins, Jeremie H Estepp, Deokumar Srivastava, Sara R Rashkin
  Genetic Epidemiology. 2024-11-05
• The ghost of parvovirus past: Idiopathic pure red cell aplasia responding to IVIG following resolved perinatal parvovirus B19 infection.
  Nathan Gray, Kacie Sims, Sara Lewis, Shaohua Lei, Nidhi Bhatt
  Pediatric Blood & Cancer. 2024-11-01

Journal Articles

• Association of Perioperative Red Blood Cell Transfusions with Venous Thromboembolism in a North American Registry  
  Ruchika Goel, Beth Shaz, Ljiljana V Vasovic, Melissa M Cushing, Paul M Ness, Clifford M Takemoto, JAMA
• Iron Status is Associated with Asthma and Lung Function in US Women  
  Brigham,E.P., McCormack,M.C., Takemoto,C.M., and Matsui,E.C., PLoS. One, 1/1/2015
• Global microRNA Expression Is Essential for Murine Mast Cell Development in Vivo  
  Oh, S. Y., Brandal S., Kapur R., Zhu Z., Takemoto C. M., Exp.Hematol, 1/1/2014
• Risk Factors for Hospital-associated Venous Thromboembolism in the Neonatal Intensive Care Unit  
  Amankwah EK, Atchison CM, Arlikar S, Ayala I, Barrett L, Branchford BR, Streiff M, Takemoto C, Goldenberg NA, Thromb Res, 1/1/2014
• Development of a New Risk Score for Hospital-Associated Venous Thromboembolism in Noncritically Ill Children: Findings from a Large Single-Institutional Case-Control S...  
  Atchison CM, Arlikar S, Amankwah E, Ayala I, Barrett L, Branchford BR, Streiff M, Takemoto C, Goldenberg NA, J Pediatr, 1/1/2014
• Von Willebrand Disease  
  Cooper S, Takemoto C., Pediatr Rev, 1/1/2014
• Hospital-acquired Venous Thromboembolism in Pediatric Patients: Incidence and Clinical Characteristics  
  Takemoto,C.M., Soji,S., Desai,K., Bharaj,R., Khanna,A., McFarland,S., Klaus,S., Irshad,A., Goldenberg,N., Strouse,J., Streiff,M.B., J. Pediatrics, 1/1/2014
• Computerized Physician Order Entry Improves Compliance With a Manual Exchange Transfusion Protocol in the Pediatric Intensive Care Unit  
  McCrory,M.C., Strouse,J.J., Takemoto,C.M., and Easley,R.B., J. Pediatr. Hematol. Oncol, 1/1/2014
• Activated Partial Thromboplastin Time and Anti-xa Measurements in Heparin Monitoring: Biochemical Basis for Discordance  
  Takemoto,C.M., Streiff,M.B., Shermock,K.M., Kraus,P.S., Chen,J., Jani,J., and Kickler,T., Am. J. Clin. Pathol, 1/1/2013
• SHP-1 Regulation of Mast Cell Function in Allergic Inflammation and Anaphylaxis  
  Zhou,L., Oh,S.Y., Zhou,Y., Yuan,B., Wu,F., Oh,M.H., Wang,Y., Takemoto,C., Van Rooijen,N., Zheng,T., and Zhu,Z., PLoS. One, 1/1/2013
• Female Factor IX Deficiency due to Maternally Inherited X-inactivation  
  Esquilin,J.M., Takemoto,C.M., and Green,N.S., Clin. Genet, 1/1/2012
• Venous Thromboembolism in Cystic Fibrosis  
  Takemoto,C.M., Pediatr. Pulmonol, 1/1/2012
• Genetic Evidence for Critical Roles of P38alpha Protein in Regulating Mast Cell Differentiation and Chemotaxis through Distinct Mechanisms  
  Hu,P., Carlesso,N., Xu,M., Liu,Y., Nebreda,A.R., Takemoto,C., and Kapur,R., J. Biol. Chem, 1/1/2012
• Safety and Efficacy of Catheter Directed Thrombolysis in Children with Deep Venous Thrombosis  
  Darbari,D.S., Desai,D., Arnaldez,F., Desai,K., Kallen,J., Strouse,J., Streiff,M.B., Hong,K., and Takemoto,C.M., Br. J. Haematol, 1/1/2012
• Thrombotic Disease in Critically Ill Children  
  McCrory,M.C., Brady,K.M., Takemoto,C., Tobias,J.D., and Easley,R.B., Pediatr. Crit Care Med, 1/1/2011
• Balanced Interactions between Lyn, the p85alpha Regulatory Subunit of Class I(A) Phosphatidylinositol-3-kinase, and SHIP Are Essential for Mast Cell Growth and Maturation  
  Ma,P., Vemula,S., Munugalavadla,V., Chen,J., Sims,E., Borneo,J., Kondo,T., Ramdas,B., Mali,R.S., Li,S., Hashino,E., Takemoto,C., and Kapur,R., Mol. Cell Biol, 1/1/2011
• The PI3K Pathway Drives the Maturation of Mast Cells via Microphthalmia Transcription Factor  
  Ma,P., Mali,R.S., Munugalavadla,V., Krishnan,S., Ramdas,B., Sims,E., Martin,H., Ghosh,J., Li,S., Chan,R.J., Krystal,G., Craig,A.W., Takemoto,C., and Kapur,R., Blood, 1/1/2011
• KIT Signaling Regulates MITF Expression through MiRNAs in Normal and Malignant Mast Cell Proliferation  
  Lee,Y.N., Brandal,S., Noel,P., Wentzel,E., Mendell,J.T., McDevitt,M.A., Kapur,R., Carter,M., Metcalfe,D.D., and Takemoto,C.M., Blood, 1/1/2011
• Heparin-induced Thrombocytopenia Screening and Management in Pediatric Patients  
  Takemoto,C.M. and Streiff,M.B., Hematology. Am. Soc. Hematol. Educ. Program, 1/1/2011
• PU1 Positively Regulates GATA-1 Expression in Mast Cells  
  Takemoto,C.M., Brandal,S., Jegga,A.G., Lee,Y.N., Shahlaee,A., Ying,Y., Dekoter,R., and McDevitt,M.A., J. Immunol, 1/1/2010
• SHP-1 Deficient Mast Cells Are Hyperresponsive to Stimulation and Critical in Initiating Allergic Inflammation in the Lung  
  Zhang,L., Oh,S.Y., Wu,X., Oh,M.H., Wu,F., Schroeder,J.T., Takemoto,C.M., Zheng,T., and Zhu,Z., J. Immunol, 1/1/2010
• Severe Congenital Neutropenia Resulting from G6PC3 Deficiency with Increased Neutrophil CXCR4 Expression and Myelokathexis  
  McDermott,D.H., De Ravin,S.S., Jun,H.S., Liu,Q., Priel,D.A., Noel,P., Takemoto,C.M., Ojode,T., Paul,S.M., Dunsmore,K.P., Hilligoss,D., Marquesen,M., Ulrick,J., Kuhns,D..., Blood, 1/1/2010
• Mast Cells--Friend or Foe?  
  Takemoto,C., J. Pediatr. Hematol. Oncol, 1/1/2010
• Noonan Syndrome: Clinical Features, Diagnosis, and Management Guidelines  
  Romano,A.A., Allanson,J.E., Dahlgren,J., Gelb,B.D., Hall,B., Pierpont,M.E., Roberts,A.E., Robinson,W., Takemoto,C.M., and Noonan,J.A., Pediatrics, 1/1/2010
• Rituximab for ITP: A Long-term Fix?  
  Takemoto,C.M., Pediatr. Blood Cancer, 1/1/2009
• Join now to see all

Books/Book Chapters

• Oski's Pediatrics: Principles and Practice 
  Chapter: General Approaches to Coagulation 
  Casella,J.F., Takemoto,C.M.Editors: J.McMillan, C.DeAngelis, R.Feigin, and D.Jones.Lippincott Williams & Wilkins, Philadelphia2006
• Casella,J.F., Pelidis,M.A., Takemoto,C.M. 
  Chapter: General Approaches to Coagulation 
  Casella,J.F., Pelidis,M.A., Takemoto,C.M.Editors: J.McMillan, C.DeAngelis, R.Feigin, and D.Jones.Lippincott Williams & Wilkins, Philadelphia2006
• Oski's Pediatrics: Principles and Practice 
  Chapter: Disorders of Coagulation Factors 
  Casella,J.F., Takemoto,C.M., Pelidis,M.A.Editors: J.McMillan, C.DeAngelis, R.Feigin, and D.Jones.Lippincott Williams & Wilkins, Philadelphia2006

Abstracts/Posters

• Associated Co-Morbidities, Healthcare Utilization, and Mortality in Hospitalized Children and Adults with Hemophilia in the United States: Updated Nationally Represent...
  Clifford M. Takemoto, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome
  Clifford Takemoto, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Case Control Study Of The Performance Of Activated Partial Thromboplastin Time Versus Anti-factor Xa Activity For The Monitoring Of Therapeutic Unfractionated Heparin ...
  Trucco M, Lehmann C, Mollenkopf N, Takemoto C., 25th Annual Meeting of the American Society of Pediatric Hematology/Oncology, Miami, FL, 1/1/2012
• Risk Factors for hospital acquired VTE in Pediatric Patients
  Takemoto C., Sohi S., Desai K., Strouse J.J., McFarland S., Klaus S., Irshad A., Streiff M, 24th Annual Meeting of the American Society of Pediatric Hematology/Oncology, Baltimore MD, 1/1/2011
• Safety and Efficacy of Catheter Directed Thrombolysis in Pediatric Patients
  Takemoto C., Desai D., Desai K., Arnaldez F., Strouse J.J., Hong K., Streiff M., 24th annual meeting of the American Society of Pediatric Hematology/Oncology, Baltimore MD, 1/1/2011
• Biochemical Determinants of Anti-Xa and aPTT Discordance for UFH Monitoring
  Takemoto C, Shermock K., Kraus P., Moore D., Greene P., Thiemann D., Petty B., Miller R., Streiff M., Kickler T., XXIII Congress of the International Society of Thrombosis and Haemostasis, Kyoto Japan, 1/1/2011
• Regulation of IL-13 in Mast Cells by the Let-7 miRNA Family
  Takemoto C., Gamper C., Lee Y-N, Mendell J., Brandal S., Powell J., McDevitt M., 97th Annual Meeting of the American Association of Immunologists, Baltimore MD, 1/1/2010
• KIT Signaling Regulates MITF Expression through microRNAs in Mastocytosis and Mast Cell Proliferation
  Takemoto C., Noel P., Mendell J., Wentzel E., Carter M., Metcalfe D.D., Lee Y-N., 96th Annual Meeting of the American Association of Immunologists, Seattle WA, 1/1/2009
• PU.1 and GATA-2 Participate in a Transcriptional Hierarchy to Regulate Mast Cell Development
  Lee Y-N, Jegga A, Brandal S, Sinha A, Gowrisankar S, DeKoter R, Yu W, McDevitt M and Takemoto C., Keystone Meeting, Mast Cells, Basophils, and IgE: Host Defense and Disease, Copper Mountain, Colorado, 1/1/2007
• Kit Signaling Regulated MITF Expression in Mastocytosis
  Lee Y-N, Noel P, Shahlaee A, Carter M, Kapur R, Wayne A, Metcalfe DD, and Takemoto C., 48th Annual Meeting of the American Society of Hematology, Orlando Florida, 1/1/2006
• Transcriptional Regulation of a Distinct GATA-1 Isoform during Selection of the Mast and Erythroid Lineages
  Takemoto C.M., Shahlaee A., Ye Y., Zeller K.I., Zablocki D. Huynh J., Huang S., DeKoter R.P., Jegga A.G., Aronow B.J., Dang C.V., and McDevitt M.A., 48th Annual Meeting of the American Society of Hematology, San Diego California, 1/1/2004
• Distinct Biological Functions of Mitf Isoforms in Mast Cell Development
  Shahlaee A., and Takemoto C.M., Keystone Meeting, Mast Cells in Physiology, Host Defense and Disease: Beyond IgE, Taos New Mexico, 1/1/2004
• Transcription Factor Networks That Regulate Mast Cell Development
  Shahlaee A., and Takemoto C.M., 47th Annual Meeting of the American Society of Hematology, San Diego California, 1/1/2003
• Join now to see all

Lectures

• Regulation of IL-13 in Mast Cells by the Let-7 miRNA Family 
  Baltimore MD - 1/7./2010
• Venous Thromboembolism in Cystic Fibrosis: Prevalence, Risk & Management 
  Atlanta Georgia - 1/9./2014
• VTE in Pediatrics 
  Baltimore MD - 1/7./2014
• State of the Art Heparin Monitoring 
  Washington DC. - 1/2./2013
• High Dose Cytoxan in Pediatrics: The Johns Hopkins Experience. 
  Texas Children's Hospital, Houston Texas - 1/26/2013
• Surgery Trials-Yes We Can! 
  Rome Italy - 1/23/2013
• VTE Prophylaxis in Pediatrics: The Johns Hopkins Children's Center Experience 
  Baltimore MD - 1/9./2012
• Heparin-induced Thrombocytopenia Screening and Management in Pediatric Patients 
  San Diego CA - 1/10/2011
• Invited Discussant for a case of Tachypnea and Tachycardia as Presenting Symptoms of an Unusual Complication in a Child 
  Baltimore MD - 1/21/2010
• Diagnosis of Hemophilia A and B 
  Belize City, Belize - 1/25/2001
• Iron Deficiency 
  St. Agnes Hospital, Baltimore MD - 1/13/2009
• Mast Cell Transcriptional Networks in Normal Development and Disease 
  Johns Hopkins Bayview Medical Center, Baltimore, MD - 1/7./2008
• Noonan Syndrome and Issues in Hematology 
  Newark, NJ - 1/18/2008
• Noonan Syndrome and Hematology-What You Need to Know 
  Towson, MD, 2007; Boca Raton, FL, 2008 - 1/17/2007
• PU.1 and GATA Factor Inter-regulation in Mast Cell Differentiation 
  Annapolis MD - 1/13/2007
• Mast Cell in Normal Development and Disease 
  Cincinnati Children's Hospital Medical Center, Cincinnati, OH - 1/26/2006
• Transcriptional Networks Regulating the Mast Lineage 
  Philadelphia, PA - 1/21/2006
• von Willebrand Disease-Diagnosis and Treatment 
  Belize City, Belize - 1/25/2001
• Join now to see all

Other

• Neonatal Anticoagulation 
  Strouse, J.J, Takemoto, C.M., eNeonatal Review
  1/1/2009
• Thromboembolic Disease in the Neonate 
  Strouse, J.J, Takemoto, C.M., eNeonatal Review
  1/1/2005